These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27268920)

  • 1. Aptamer-modified PLGA nanoparticle delivery of triplex forming oligonucleotide for targeted prostate cancer therapy.
    Jiao J; Zou Q; Zou MH; Guo RM; Zhu S; Zhang Y
    Neoplasma; 2016; 63(4):569-75. PubMed ID: 27268920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.
    Dhar S; Gu FX; Langer R; Farokhzad OC; Lippard SJ
    Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17356-61. PubMed ID: 18978032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
    Cheng J; Teply BA; Sherifi I; Sung J; Luther G; Gu FX; Levy-Nissenbaum E; Radovic-Moreno AF; Langer R; Farokhzad OC
    Biomaterials; 2007 Feb; 28(5):869-76. PubMed ID: 17055572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.
    Farokhzad OC; Cheng J; Teply BA; Sherifi I; Jon S; Kantoff PW; Richie JP; Langer R
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6315-20. PubMed ID: 16606824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-
    Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z
    Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy.
    Chen Z; Tai Z; Gu F; Hu C; Zhu Q; Gao S
    Eur J Pharm Biopharm; 2016 Oct; 107():130-41. PubMed ID: 27393562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
    Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
    Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol-Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non-Small Cell Lung Cancer In Vitro.
    Alibolandi M; Ramezani M; Abnous K; Hadizadeh F
    J Pharm Sci; 2016 May; 105(5):1741-1750. PubMed ID: 27039356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plumbagin-loaded aptamer-targeted poly D,L-lactic-co-glycolic acid-b-polyethylene glycol nanoparticles for prostate cancer therapy.
    Pan M; Li W; Yang J; Li Z; Zhao J; Xiao Y; Xing Y; Zhang X; Ju W
    Medicine (Baltimore); 2017 Jul; 96(30):e7405. PubMed ID: 28746182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells.
    Farokhzad OC; Jon S; Khademhosseini A; Tran TN; Lavan DA; Langer R
    Cancer Res; 2004 Nov; 64(21):7668-72. PubMed ID: 15520166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
    Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
    Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo.
    Dhar S; Kolishetti N; Lippard SJ; Farokhzad OC
    Proc Natl Acad Sci U S A; 2011 Feb; 108(5):1850-5. PubMed ID: 21233423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
    Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
    Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery.
    Taghavi S; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
    Cancer Lett; 2017 Aug; 400():1-8. PubMed ID: 28412238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer.
    Alibolandi M; Ramezani M; Abnous K; Sadeghi F; Atyabi F; Asouri M; Ahmadi AA; Hadizadeh F
    J Control Release; 2015 Jul; 209():88-100. PubMed ID: 25912964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers.
    Gu F; Zhang L; Teply BA; Mann N; Wang A; Radovic-Moreno AF; Langer R; Farokhzad OC
    Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2586-91. PubMed ID: 18272481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells.
    Mosafer J; Teymouri M; Abnous K; Tafaghodi M; Ramezani M
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():123-133. PubMed ID: 28024568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer.
    Wu M; Zhao H; Guo L; Wang Y; Song J; Zhao X; Li C; Hao L; Wang D; Tang J
    Drug Deliv; 2018 Nov; 25(1):226-240. PubMed ID: 29313393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-targeted biodegradable nanoparticles loaded with androgen receptor silencing constructs eradicate xenograft tumors in mice.
    Yang J; Xie SX; Huang Y; Ling M; Liu J; Ran Y; Wang Y; Thrasher JB; Berkland C; Li B
    Nanomedicine (Lond); 2012 Sep; 7(9):1297-309. PubMed ID: 22583574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
    Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
    Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.